| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7872264a2ec77f4c2e58f5bba3b35d9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-68 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K131-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
| filingDate |
2021-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a420b7f36798a5d4154fbeb1533a4ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f958569dc76180d4f1887e3acaaf087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_928757b931a1eea1b5e3b09b8f158c3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_861f168cb61540ab1f8d1f64fbcbfba9 |
| publicationDate |
2021-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113384622-A |
| titleOfInvention |
Use of psyllium extract in preparation of medicament for treating cardiac hypertrophy |
| abstract |
The invention discloses the use of a psyllium extract in preparing a medicament for treating cardiac hypertrophy. The present invention utilizes the experimental animal model of isoproterenol-induced myocardial hypertrophy to carry out in vivo drug efficacy experiments, and the research results show that: the psyllium extract of the present invention can significantly improve the cardiac function of isoproterenol-induced myocardial hypertrophy mice, and can The myocardial morphological enlargement and the high expression of embryonic genes are obviously inhibited, and it is expected to be used for the preparation of a drug for prevention and treatment or an adjuvant treatment of myocardial hypertrophy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115475222-A |
| priorityDate |
2021-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |